Free Trial

Neogen (NEOG) Competitors

Neogen logo
$4.74 -0.12 (-2.47%)
Closing price 04:00 PM Eastern
Extended Trading
$4.73 -0.01 (-0.19%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NEOG vs. HAE, ICUI, XRAY, QDEL, STAA, CERS, OSUR, UTMD, ANIK, and WST

Should you be buying Neogen stock or one of its competitors? The main competitors of Neogen include Haemonetics (HAE), ICU Medical (ICUI), DENTSPLY SIRONA (XRAY), QuidelOrtho (QDEL), STAAR Surgical (STAA), Cerus (CERS), OraSure Technologies (OSUR), Utah Medical Products (UTMD), Anika Therapeutics (ANIK), and West Pharmaceutical Services (WST). These companies are all part of the "health care supplies" industry.

Neogen vs. Its Competitors

Haemonetics (NYSE:HAE) and Neogen (NASDAQ:NEOG) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, analyst recommendations, institutional ownership, risk, earnings, valuation and dividends.

Haemonetics has a net margin of 12.32% compared to Neogen's net margin of -53.56%. Haemonetics' return on equity of 26.37% beat Neogen's return on equity.

Company Net Margins Return on Equity Return on Assets
Haemonetics12.32% 26.37% 9.22%
Neogen -53.56%2.69%1.82%

Haemonetics has higher revenue and earnings than Neogen. Neogen is trading at a lower price-to-earnings ratio than Haemonetics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Haemonetics$1.36B2.56$167.68M$3.3121.92
Neogen$924.22M1.11-$9.42M-$2.23-2.13

Haemonetics has a beta of 0.39, indicating that its stock price is 61% less volatile than the S&P 500. Comparatively, Neogen has a beta of 1.77, indicating that its stock price is 77% more volatile than the S&P 500.

Haemonetics currently has a consensus target price of $97.30, suggesting a potential upside of 34.11%. Neogen has a consensus target price of $7.50, suggesting a potential upside of 58.23%. Given Neogen's higher possible upside, analysts plainly believe Neogen is more favorable than Haemonetics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Haemonetics
1 Sell rating(s)
0 Hold rating(s)
8 Buy rating(s)
2 Strong Buy rating(s)
3.00
Neogen
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50

In the previous week, Neogen had 11 more articles in the media than Haemonetics. MarketBeat recorded 26 mentions for Neogen and 15 mentions for Haemonetics. Haemonetics' average media sentiment score of 0.43 beat Neogen's score of 0.32 indicating that Haemonetics is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Haemonetics
5 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
Neogen
7 Very Positive mention(s)
0 Positive mention(s)
13 Neutral mention(s)
6 Negative mention(s)
0 Very Negative mention(s)
Neutral

99.7% of Haemonetics shares are held by institutional investors. Comparatively, 96.7% of Neogen shares are held by institutional investors. 1.8% of Haemonetics shares are held by insiders. Comparatively, 1.1% of Neogen shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Haemonetics beats Neogen on 14 of the 17 factors compared between the two stocks.

Get Neogen News Delivered to You Automatically

Sign up to receive the latest news and ratings for NEOG and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NEOG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NEOG vs. The Competition

MetricNeogenMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$1.05B$10.12B$5.52B$9.41B
Dividend YieldN/A2.05%3.80%4.04%
P/E Ratio13.5016.5928.0419.84
Price / Sales1.1129.60429.5399.59
Price / Cash4.7422.2635.8457.94
Price / Book0.333.578.125.65
Net Income-$9.42M$235.43M$3.25B$258.00M
7 Day Performance-12.06%-1.67%0.97%2.09%
1 Month Performance-5.01%2.91%7.36%11.13%
1 Year Performance-71.89%-16.44%31.31%18.40%

Neogen Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NEOG
Neogen
4.1545 of 5 stars
$4.74
-2.5%
$7.50
+58.2%
-72.3%$1.05B$924.22M-2.132,110Trending News
HAE
Haemonetics
4.8923 of 5 stars
$75.00
-2.4%
$96.80
+29.1%
-18.7%$3.60B$1.36B22.663,023
ICUI
ICU Medical
4.3776 of 5 stars
$129.71
-4.2%
$192.67
+48.5%
-2.5%$3.19B$2.38B-33.8715,000News Coverage
Positive News
XRAY
DENTSPLY SIRONA
4.5287 of 5 stars
$15.94
-4.4%
$20.36
+27.8%
-42.7%$3.18B$3.79B-3.5114,000Analyst Revision
QDEL
QuidelOrtho
4.454 of 5 stars
$29.22
-3.2%
$44.33
+51.7%
-23.4%$1.98B$2.78B-5.886,600News Coverage
Gap Up
STAA
STAAR Surgical
3.3378 of 5 stars
$16.61
-7.0%
$24.63
+48.3%
-61.0%$822.63M$279.13M-11.531,211Analyst Forecast
Gap Up
CERS
Cerus
2.6677 of 5 stars
$1.45
-5.8%
$3.50
+141.4%
-41.9%$277.18M$180.27M-14.50290Positive News
OSUR
OraSure Technologies
2.5804 of 5 stars
$3.05
-1.0%
$3.00
-1.6%
-26.3%$228.14M$185.83M-7.26840
UTMD
Utah Medical Products
2.1718 of 5 stars
$57.19
-2.1%
N/A-22.9%$185.87M$40.90M15.13180Positive News
Upcoming Earnings
ANIK
Anika Therapeutics
4.3265 of 5 stars
$10.81
-3.9%
$20.00
+85.0%
-60.9%$155.02M$119.91M-2.79300
WST
West Pharmaceutical Services
4.8069 of 5 stars
$221.49
-0.3%
$320.00
+44.5%
-32.2%$15.91B$2.90B34.7710,600Positive News
Upcoming Earnings

Related Companies and Tools


This page (NASDAQ:NEOG) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners